Calibr at Scripps Research
Alex Brooks has a diverse work experience in the healthcare and clinical research field. Alex is currently the Director of Clinical Operations at Calibr at Scripps Research, a position they started in October 2021. Before that, they worked as an Associate Clinical Trial Manager Director at IQVIA from April 2020 to October 2021. Prior to that, they held positions such as Clinical Trials Manager at Viome, Clinical Trials Manager and Supervisor at Seattle Children's, Lead Clinical Research Coordinator at Swedish Cancer Institute, and various roles at Seattle Cancer Care Alliance, University of Washington, Fred Hutchinson Cancer Research Center. Additionally, Alex has experience as a Patient Care Technician at Virginia Mason Medical Center and as a Medical Billing Specialist at Northwestern Clinic of Naturopathic Medicine.
Alex Brooks studied Molecular, Cellular, Developmental Biology at the University of Washington. They obtained additional certifications including Certified Clinical Research Professional from The Society of Clinical Research Associates in November 2016, Phlebotomist in 2008 (institution unknown), and Nursing Assistant from the Washington State Department of Health. Specific month and year information is unavailable for the Phlebotomist and Nursing Assistant certifications.
This person is not in any offices
Calibr at Scripps Research
1 followers
The California Institute for Biomedical Research (Calibr) is a first-of-its-kind, nonprofit translational research institute dedicated to accelerating the next generation of medicines. Affiliated with Scripps Research—among the most innovative institutes worldwide—we spearhead drug discovery from a steady flow of pioneering science. Our self-sustaining model encourages broad and bold exploration with far-reaching goals, yet rapid transition of our most successful, high-impact programs into the clinic. We pursue audacious and imaginative ideas—bridging scientific and technological advances to develop new medicines for unmet medical needs. Our pipeline programs range from cancer to infectious diseases and from discovery to early clinical trial stages, all aimed at preventing disease and healing humans around the world. We bring together leaders in research, drug development, and business to answer important biological questions and develop new interventions to treat, cure, and prevent disease. Our infrastructure and expertise extend from high-throughput screening and protein engineering to pharmacology and clinical development. Calibr’s research space includes a newly renovated 35,000 square foot facility in La Jolla, CA, which houses over 100 interdisciplinary scientists and staff with state-of-the-art instrumentation. This infrastructure, combined with Calibr’s drug discovery expertise, enables projects rooted in novel therapeutic mechanisms to progress from the laboratory through preclinical development and ultimately to the clinic through commercial, federal, or foundation partnerships.